Association between the metabolic syndrome and chronic kidney disease in Chinese adults
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The metabolic syndrome is a common risk factor for cardiovascular and chronic kidney disease (CKD) in Western populations. We examined the relationship between the metabolic syndrome and risk of CKD in Chinese adults. METHODS: A cross-sectional survey was conducted in a nationally representative sample of 15 160 Chinese adults aged 35-74 years. The metabolic syndrome was defined as the presence of three or more of the following risk factors: elevated blood pressure, low high density lipoprotein (HDL)-cholesterol, high triglycerides, elevated plasma glucose and abdominal obesity. CKD was defined as an estimated glomerular filtration rate<60 ml/min/1.73 m2 and elevated serum creatinine was defined as >or=1.14 mg/dl in men and >or=0.97 mg/dl in women (>or=95th percentile of serum creatinine in Chinese men and women aged 35-44 years without hypertension or diabetes, respectively). RESULTS: The multivariate-adjusted odds ratios [95% confidence interval (CI)] of CKD and elevated serum creatinine in participants with compared to those without the metabolic syndrome were 1.64 (1.16, 2.32) and 1.36 (1.07, 1.73), respectively. Compared to participants without any components of the metabolic syndrome, the multivariate-adjusted odds ratios (95% CI) of CKD were 1.51 (1.02, 2.23), 1.50 (0.97, 2.32), 2.13 (1.30, 3.50) and 2.72 (1.50, 4.93) for those with 1, 2, 3, and 4 or 5 components, respectively. The corresponding multivariate-adjusted odds ratios (95% CI) of elevated serum creatinine were 1.11 (0.88, 1.40), 1.39 (1.07, 2.04), 1.47 (1.06, 2.04) and 2.00 (1.32, 3.03), respectively. CONCLUSIONS: These findings suggest that the metabolic syndrome might be an important risk factor for CKD in Chinese adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., & Levey, A. S. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50007 · Cited by 2,768 · cited 1×
“In the US, diabetes and hypertension are the most common underlying causes of CKD [2,4].”
(2000) · Journal of the American Society of Nephrology · Cited by 1,718
Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1769 · Cited by 1,710 · cited 1×
“The metabolic syndrome, characterized by a clustering of abdominal obesity, hypertriglyceridaemia, low high-density lipoprotein (HDL) cholesterol, elevated blood pressure (BP), and high fasting glucose, has been associated with an increased risk for the development of diabetes and CVD as well as an increased mortality…”
Human blood pressure determination by sphygmomanometry.
Perloff, D., Grim, C., Flack, J., Frohlich, E. D., Hill, M., McDonald, M., & Morgenstern, B. Z. (1993) · Circulation · doi:10.1161/01.cir.88.5.2460 · Cited by 1,591 · cited 1×
“During the clinical examination, BP and anthropometric measurements were collected by trained and certified observers using standard protocols and technique [12].”
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults
Chen, J., Muntner, P., Hamm, L. L., Jones, D. W., Batuman, V., Fonseca, V., Whelton, P. K., & He, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00007 · Cited by 1,359 · cited 4×
“89-fold increased risk of CKD and microalbuminuria, respectively, in US adults [9].”
InfluentialSelf-citationChronic kidney disease: the global challenge
El Nahas, A. M., & Bello, A. K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17789-7 · Cited by 1,195
Prevalence of the metabolic syndrome and overweight among adults in China
Gu, D., Reynolds, K., Wu, X., Chen, J., Duan, X., Reynolds, R. F., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66375-1 · Cited by 917 · cited 2×
“These findings have important clinical and public health implications because the metabolic syndrome and CKD are becoming common in the Chinese general population [3,11].”
Self-citationRenal Insufficiency and Subsequent Death Resulting from Cardiovascular Disease in the United States
Muntner, P., He, J., Hamm, L., Loria, C., & Whelton, P. K. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133745 · Cited by 829
Self-citation
Cited by
Items 101–177 of 177
Renal Dysfunction and Inflammatory Markers in Hypertensive Patients seen in a University Hospital
Braga, F. L. M., de Arruda, I. K. G., Diniz, A. D. S., Cabral, P. C., de Lemos, M. D. C. C., Braga, M. D. M., & Chaves, H. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20130102 · Cited by 11
Chen, W., Tang, D., Dai, Y., & Diao, H. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9672 · Cited by 10
“Metabolic abnormalities are an example of these acquired external factors (52,53).”
BackgroundPrevalence of Sleep Apnea and its Associated Factors in Chronic Kidney Disease Patients.
Moradzadeh, M., Mirmohammadkhani, M., Tamadon, M. R., Mansori, K., & Malek, F. (2021) · PubMed Central · Cited by 10
Bi, H., Wu, Y.-Q., Zhao, C., & Long, G. (2014) · Europe PMC (PubMed Central) · Cited by 9
Wang, X., Wang, H., Li, J., Gao, X., Han, Y., Teng, W., Shan, Z., & Lai, Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s337190 · Cited by 9
Korantzopoulos, P. G., Elisaf, M., & Milionis, H. J. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm525 · Cited by 9
“In fact, central obesity, as assessed by the waist circumference, has been indicated as an independent risk factor for renal dysfunction [9,12,14,16,19].”
BackgroundResultYoussef, S. M., Najah, M., Slimani, A., Khaldoun, B. H., Fadoua, N., Fadhel, N. M., & Slimane, M. N. (2013) · PPAR Research · doi:10.1155/2013/329862 · Cited by 8
“Many studies found a significant association betweenMS and CKD and consistently demonstrated an increased risk parallel to the number of MS traits [28–30].”
BackgroundLu, M., Chen, I.-J., Hsu, L.-T., Chen, Y.-J., Tsou, M.-T., Tung, T., & Chen, J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.748037 · Cited by 8
“Although metabolic syndrome itself is an independent risk factor associated with CKD, dyslipidemia (including both hypertriglyceridemia and low HDL-C level) is not significantly associated with the development of CKD (26, 29, 30, 33, 34, 43).”
BackgroundSelf-citationLiu, H., Yu, J., Chen, F., Wang, J., Chen, S., Wang, F., & Hu, D. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0771 · Cited by 8
Han, B. L., Guan, Q., Chafeeva, I., Mendelson, A. A., da Roza, G., Liggins, R., Kizhakkedathu, J. N., & Du, C. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13038 · Cited by 8
Kuo, C.-M., Chien, W.-H., Shen, H.-C., Hu, Y., Chen, Y.-F., & Tung, T. (2013) · BioMed Research International · doi:10.1155/2013/214128 · Cited by 7
Метаболічний синдром і ризик хронічної хвороби нирок
Melnyk, O. O. (2021) · KIDNEYS · doi:10.22141/2307-1257.6.2.2017.102785 · Cited by 8
Ethnic variation in the impact of metabolic syndrome components and chronic kidney disease
Sabanayagam, C., Teo, B. W., Tai, E. S., Jafar, T. H., & Wong, T. Y. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.01.006 · Cited by 7
Síndrome metabólico y enfermedad renal
Molina, P. (2010) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(10)70570-8 · Cited by 7
Srivastava, N., Singh, R. G., Usha, Kumar, A., & Singh, S. V. (2017) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.198114 · Cited by 6
Skalny, A. V., Chang, J., Bobrovnitsky, I. P., Kopylov, P., Геннадиевна, С. М., Huang, S., Paoliello, M. M. B., Ivanova, E. S., Wang, W., & Tinkov, A. A. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02430-2 · Cited by 6
“these findings corroborate the existing data on the role of Hg as a nephrotoxic agent [38], and may be indicative of higher risk of chronic kidney disease in obesity and metabolic syndrome [39].”
ResultXu, L., Yu, W., Huang, P. C., Li, C., Li, Y., Wang, M., Xu, Q., Wang, J., Zheng, C., Qu, B., et al. (2015) · International Journal of Endocrinology · doi:10.1155/2015/715871 · Cited by 6
“For example, a previous study in China that found WC was associated with increased CKD risk included subjects aged 35–74 years [28], while two other studies in China that failed to find significant association included younger subjects (≥30 years old [29] and ≥20 years old [27]).”
ResultSerum Level of Uromodulin as an Early Predictor Marker of Kidney Disorders
Shebini, S. M. E., Essa, H. A., Moaty, M. I. A., Ahmed, N. H., Hussein, A., Mohamed, M. S., & Tapozada, S. T. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.5663 · Cited by 5
“High susceptibility of overweight and obese subjects to CKD was reported in Norway with a relative risk of 1.77 [7].”
BackgroundInfluentialWen, J., Guo, C.-X., Lu, M., Lu, Y., Huang, Y., Liu, X., Li, Y., Huang, Z., Zhang, Y., & Yuan, H. (2016) · International Urology and Nephrology · doi:10.1007/s11255-015-1172-0 · Cited by 5
Liang, Y. (2013) · Asia Pacific Journal of Public Health · doi:10.1177/1010539513495270 · Cited by 5
Polozova, E. I., Sorokina, N. N., Пузанова, Е. В., & Seskina, A. A. (2019) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2019-6-170-175 · Cited by 5
Interactions between CKD and MetS and the Development of CVD
Aihara, K., Mogi, M., Shibata, R., Bishop‐Bailey, D., & Ma, X. L. (2011) · Cardiology Research and Practice · doi:10.4061/2011/878065 · Cited by 5
Metabolic Syndrome—What We Know and What We Don't Know
Mani, A., Radhakrishnan, J., Wang, H., Mani, A., Mani, M.-A., Nelson-Williams, C. J., Carew, K. S., Mane, S., Najmabadi, H., Wu, D., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007040522 · Cited by 4
Zaman, S. B., Gupta, R. D., Pramual, P., Khan, R. K., Sujimongkol, C., Hossain, N., Haider, M. R., Karim, M. N., Kibria, G. M. A., & Islam, S. M. S. (2021) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2021.100026 · Cited by 4
Medeiros, T., do Rosário, N. F., Gama, N. A., Mérida, L. A. D., Storch, A. S., Ferraz, L., Lopes, P. D. F., Silva, A. A., & Almeida, J. R. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.015 · Cited by 3
Cafeteria Diet-Induced Obesity Worsens Experimental CKD
Laget, J., Cortijo, I., Boukhaled, J. H., Muyor, K., Duranton, F., Jover, B. F., Raynaud, F., Lajoix, A., Argilés, À., & Gayrard, N. (2023) · Nutrients · doi:10.3390/nu15153331 · Cited by 3
Механизмы поражения почек при ожирении и метаболическом синдроме (обзор литературы)
Шишкова, Ю. Н., Миняйлова, Н. Н., Иванович, Р. Ю., & Казакова, Л. М. (2018) · Matʹ i ditâ v Kuzbasse · Cited by 3
Association of Serum Cystatin C with Metabolic Syndrome and Its Related Components in Korean Adults
Kim, S. Y., Song, S. H., Jeon, Y. K., Kim, J. R., Bae, J. H., Kim, S. S., Lee, S. H., Son, S. M., Kim, I. J., Kim, Y. K., et al. (2008) · Korean Diabetes Journal · doi:10.4093/kdj.2008.32.5.409 · Cited by 3
BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
Murkamilov, I. T., Sabirov, I. S., Fomin, V. V., & Yusupov, F. A. (2017) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2017-13-3-422-426 · Cited by 3
Metabolic syndrome and kidney: nephroprotection and reduction of cardiovascular risk
Nedogoda, S. V., Chumachek, E. V., Цома, В. В., Salasyuk, A. S., Смирнова, В. О., Hripaeva, V. Y., Палашкин, Р. В., & Popova, E. A. (2018) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2018-24-3-369-378 · Cited by 3
Jhorawat, R., Bansal, N., Beniwal, P., Agarwal, D., & Malhotra, V. (2017) · Indian Journal of Nephrology · doi:10.4103/ijn.ijn_361_16 · Cited by 2
“com syndrome and recognized in CKD patients has been directly associated with increased cardiovascular mortality in many studies.[3,4]”
BackgroundRenal functions in patients with metabolic syndrome
Augusthy, A., Sahu, S., Jeppu, A. K., & Jawalekar, S. (2018) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2018.i08.02 · Cited by 1
“Individuals with metabolic syndrome are at increased risk for developing chronic kidney disease (CKD) [2-5].”
BackgroundPERFIL EPIDEMIOLÓGICO DOS PACIENTES EM HEMODIÁLISE NA SANTA CASA DE CARIDADE DE DIAMANTINA
Lages, M. B., Santos, A. P., Gaiad, T. P., & Ferreira, C. M. D. R. (2022) · CADERNOS DE EDUCAÇÃO SAÚDE E FISIOTERAPIA · doi:10.18310/2358-8306.v9n19.a3 · Cited by 1
Ritz, E. (2006) · Cited by 1
Estimación de la tasa de filtración glomerular en personas con y sin síndrome metabólico
Lizardo, M., Navarro, M. D. P. M., Camacho, M., Magallanes-Hernández, M. A., Pacheco-Gutiérrez, R. G., López-Bordones, M., Cabello, R., González-Mayo, G., Vicci, H., & Dorta, L. (2016) · Revista Facultad de Ciencias de la Salud UDES · doi:10.20320/rfcsudes.v3i1.102 · Cited by 1
Patrakitkomjorn, S., Khongsri, S., Chawarit, S., Promdee, L., & Teerajetgul, Y. (2011) · Archives of Allied Health Sciences · Cited by 1
The cardiometabolic syndrome and chronic kidney disease
Yerram, P., Karuparthi, P. R., Saab, G., & Whaley‐Connell, A. T. (2008) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-008-0019-y · Cited by 1
“Two other studies investigating the risk of CKD with CMS in the Chinese and Japanese populations showed similar results [8, 12 ], further confirming the association between CMS and CKD.”
Result¿Otros factores asociados con síndrome metabólico ?
Menco, C. R., & Pérez, A. D. (2011) · Ciencia y Salud Virtual · doi:10.22519/21455333.300 · Cited by 1
“Esta asociación persistió aún después de excluir los pacientes diabéticos [48-49] debido a las limitaciones metodológicas presentes en este tipo de estudios, éstos no pueden demostrar si el SM es causa o efecto del daño renal crónico [50].”
BackgroundVigan, J., Alassani, A. S. C., Ahissou, M. M. A., Sabi, K. A., Assogba, U., Attolou, V., & Djrolo, F. (2016) · Open Journal of Nephrology · doi:10.4236/ojneph.2016.64022 · Cited by 1
“This same association was reported by Chen (p 0.0001) who used as criteria for metabolic syndrome definition, NCEP-ATPIII [21].”
MethodInfluentialOlfa, B. O. S., Ati, Z. E., Hanen, M., Knani, I., Hassan, B., Mohsen, K., & Hammami, M. (2018) · Biochemistry & Molecular Biology Journal · doi:10.21767/2471-8084.100052 · Cited by 1
“Keywords: Metabolic syndrome; Cardiovascular disease; Hemodialysis Introduction Chronic kidney disease (CKD), and mostly, the end stage renal disease (ESRD) are subject to further studies because there is worldwide public health problem [1].”
BackgroundInfluentialMetabolic syndrome X and its vascular complications as a predictor of level mortality
Бойченко, П. К., ZHigalkina, A. V., & Moskvin, A. A. (2019) · ТЕНДЕНЦИИ РАЗВИТИЯ НАУКИ И ОБРАЗОВАНИЯ · doi:10.18411/lj-01-2019-99 · Cited by 1
Study on the association of SLC2A9 rs16890979 with gout in 410 Vietnamese individuals
Thang, N. T. M., Ngoc, N. T., Nga, N. T., Hải, N. V., & Dương, N. T. (2021) · TAP CHI SINH HOC · doi:10.15625/2615-9023/15551 · Cited by 1
“MetSs have also been proven to be closely related to the chronic kidney disease, which can be determined based on the estimated Glomerular Filtration Rate (eGFR) and blood creatinine level.”
BackgroundInfluentialKatz, I. J. (2011) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 1
Lu, M., Chen, I.-J., Yeh, W.-C., Chuang, H., Tsao, Y.-C., Li, W.-C., Tzeng, I., Tung, T., & Chen, J. (2020) · doi:10.21203/rs.2.23147/v1 · Cited by 1
Self-citationOcena stężenia wybranych interleukin i parametrów funkcji nerek u chorych z zespołem metabolicznym
(2015) · Wielkopolska Digital Library · Cited by 1
Rozas, M. G. (2013) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/4455
Lai, F. M., To, K., & Choi, P. C. L. (2008) · Hong Kong Journal of Nephrology · doi:10.1016/s1561-5413(08)60021-6
Controversies on Obesity and CKD
Ito, S. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0046
Metabolic Syndrome and the Risk for Chronic Kidney Disease among Korean Women
Chae, S. K., Lee, J. S., Chun, J. H., & Park, H. S. (2009) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2009.30.2.98
A Mathematical Model to Estimate the Risk of Microalbuminuria in an Overweight Adult Male Population
Chen, B., Xu, W., Chen, R., Li, X., Ye, B., & Chen, Y. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900621
Insulin resistance, inflammatory markers and alcohol consumption in IgA glomerulonephritis
Kaartinen, K. (2009) · Tampere University Institutional Repository (Tampere University)
Kidney Disease in Obesity and Metabolic Syndrome
Rosas, S. E., William, J. H., & Kramer, H. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_49-1
山田, 奈. (2016) · Institutional Repositories DataBase (IRDB)
Metabolic Syndrome and Chronic Kidney Disease
Gjata, M., Nelaj, E., Zheni, G., Koroshi, A., & Tase, M. (2009)
Mattu, S. J. (2016) · eSpace (Curtin University)
Egbi, O. G., Unuigbe, E. I., & Oviasu, E. (2018) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20181754
Goel, H. K., Aggarwal, O., Kumar, A., Lali, P., & Chandra, L. (2018) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20183245
“Chen et al, has shown that there is a graded prevalence of CKD or microalbuminuria according to the number of metabolic syndrome components.(21) This was in support with finding in our study where mean urinary microalbumin was higher in MS cases as compared to controls (56.”
ResultSerum Vitamin D Level in Chronic Kidney Disease Patients from Gaza Strip
Abdallah, S. A. (2015)
Pseudohypercreatininemia after Sustanon Injection
Hüzmeli, C., Sağlam, M., Döner, B., Çağlar, S., & Güngör, Ö. (2017) · SM Journal of Nephrology and Kidney Diseases · doi:10.36876/smjnkd.1005s
Study of renal functions in metabolic syndrome and its correlation with various parameters
Anand, N., & Vidya, T. (2020) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20200763 · Cited by 1
“Similar results were seen in studies done by Chen et al, Kurella et al, Kitiyakara et al, Bonnett et al, Sun et al, Watanabe et al, Ryu S et al, Wang Q et al.(13-20)”
BackgroundMethodResultInfluentialKidney Disease in Obesity and Metabolic Syndrome
William, J. H., Kramer, H., & Rosas, S. E. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_49-2
Kidney Disease in Obesity and Metabolic Syndrome
William, J. H., Kramer, H., & Rosas, S. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_49
Gorbatenko, O. А., Venidiktova, D. Y., & Borsukov, A. V. (2022) · Medical alphabet · doi:10.33667/2078-5631-2022-18-35-40
Urinary biomarkers in children with kidney diseases taking into account obesity
Nastausheva, T. L., Chan, A. V., Николаевна, К. Е., Volosovets, G. G., Chichuga, E. M., Chubarov, T. V., Gurovich, O. V., & Grebennikova, I. V. (2022) · Pediatrician (St Petersburg) · doi:10.17816/ped13465-74
“У взрослых доказано, что вероятность снижения скорости клубочковой фильтрации (СКФ) менее 60 мл/мин значимо возрастает при наличии ожирения [10].”
Рудіченко, В. М., Barna, O. М., & Korost, Y. V. (2024) · Medicine of Ukraine · doi:10.37987/1997-9894.2024.1(277).299287
Cui, Y., Li, Y., Yue, S., & Yu, P. (2025) · Research Square · doi:10.21203/rs.3.rs-7121363/v1
Shevandova, A. A., Ametova, L. O., Makalish, T. P., Владимировна, Ч. И., Sorokina, L. E., Писарев, А. А., & Фомочкина, И. И. (2025) · Avicenna Bulletin · doi:10.25005/2074-0581-2025-27-3-683-694
“Наличие ме - таболических нарушений увеличивает вероятность развития ХБП у пациентов старше 20 лет в 2,6 раза, при этом отмечается прямая зависимость с количеством диагностических критериев МС [3, 4].”
InfluentialExercício físico em adultos com síndrome metabólica: uma revisão integrativa
Pivatto, F., de Oliveira, D. V., Marques, I. V. P., Acêncio, F. R., & Ieker, A. S. D. (2025) · Arquivos do Mudi · doi:10.4025/arqmudi.v29i4.77088
Expósito, C., & de Medicina, U. A. D. B. D. (2017) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Effects of physical activity on cardiovascular risk factors and comorbidities in CKD population
Diekhöfer genannt Luthe, A. N. R. (2017) · Online Publication Service of Würzburg University (Würzburg University)
Li, Z., Si, Z., Zhang, S., Wang, N., Zhang, H. F., Li, X., Xue, L., & Wu, J. T. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-01165-x
“This may be because these oil workers with metabolic syndrome had a high incidence rate in the non-exposed group [26], thereby diminishing the effect of high temperature as an occupational hazard.”
Shevandova, A. A., Османовна, А. Л., Makalish, T. P., Владимировна, Ч. И., Евгеньевна, С. Л., Аркадьевич, П. А., & Фомочкина, И. И. (2025) · Avicenna Bulletin
Jiang, W., Zhang, F., Zhang, X., Zhong, Y., & Chen, Y. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2646035
“Similarly, a study by Chen et al. found that the cumulative burden of metabolic syndrome components was associated with a higher risk of CKd in a Chinese population [26].”
Pehlıvan, S., Oyacı, Y., Şenkal, N., Kama, E. T., Pehlıvan, M., Tükek, T., & Medetalibeyoğlu, A. (2026) · Epigenomics · doi:10.1080/17501911.2026.2700472
Arab, W., Mayurapak, C., Phonphet, C., Chaimay, B., & Suwanno, J. (2021) · Thai Journal of Cardio-Thoracic Nursing
Александровна, Г. О., Юрьевна, В. Д., & Васильевич, Б. А. (2022) · Medical alphabet
Metadata
- Authors
- Chen, J., Gu, D., Chen, C.-S., Wu, X., Hamm, L. L., Muntner, P., Batuman, V., Lee, C.-H., Whelton, P. K., & He, J.
- Affiliations
- Tulane University (US)
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01-25
- Volume
- 22
- Issue
- 4
- Pages
- 1100-1106
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2150827260
- Cited by
- 164
- References
- 20
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 1 · 2022: 5 · 2021: 9 · 2020: 3 · 2019: 7 · 2018: 15 · 2017: 11 · 2016: 8 · 2015: 13 · 2014: 12 · 2013: 14 · 2012: 7
- FWCI
- 8.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nephrology Dialysis Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK60963, U01DK060963)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD043451)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- metabolic syndrome, chronic kidney disease, creatinine elevation, risk factors, Chinese adults, hypertension, low HDL cholesterol, hypertriglyceridemia, hyperglycemia, abdominal obesity, estimated glomerular filtration rate
- MeSH terms
- Adult, Aged, Blood Glucose, China, Chronic Disease, Creatinine, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Kidney Diseases, Male, Middle Aged, Obesity, Risk Factors, Body Mass Index, Multivariate Analysis, Odds Ratio, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.